Skip to main content

letter

. 1992 Sep;68(3):342. doi: 10.1136/hrt.68.9.342-a

Effect of early intravenous heparin on coronary patency infarct size, and bleeding complications after alteplase thrombolysis

David R Massel ^1,², David De Bono ^1,²

PMCID: PMC1025085 PMID: 1389772

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Morris J. A., Gardner M. J. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J (Clin Res Ed) 1988 May 7;296(6632):1313–1316. doi: 10.1136/bmj.296.6632.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
Schwartz D., Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967 Aug;20(8):637–648. doi: 10.1016/0021-9681(67)90041-0. [DOI] [PubMed] [Google Scholar]
de Bono D. P., Simoons M. L., Tijssen J., Arnold A. E., Betriu A., Burgersdijk C., López Bescos L., Mueller E., Pfisterer M., Van de Werf F. Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. Br Heart J. 1992 Feb;67(2):122–128. doi: 10.1136/hrt.67.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES